-
1 Comment
IM Cannabis Corp. Common Shares is currently in a long term uptrend where the price is trading 18.7% above its 200 day moving average.
From a valuation standpoint, the stock is 3537.1% more expensive than other stocks from the Other sector with a price to sales ratio of 33.7.
Based on the above factors, IM Cannabis Corp. Common Shares gets an overall score of 1/5.
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | CA44969Q2080 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Dividend Yield | None |
|---|---|
| Target Price | 8.221 |
| Market Cap | 5M |
| Beta | 2.81 |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IMCC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
